These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25044007)

  • 1. Comparing translational population-PBPK modelling of brain microdialysis with bottom-up prediction of brain-to-plasma distribution in rat and human.
    Ball K; Bouzom F; Scherrmann JM; Walther B; Declèves X
    Biopharm Drug Dispos; 2014 Nov; 35(8):485-99. PubMed ID: 25044007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A physiologically based modeling strategy during preclinical CNS drug development.
    Ball K; Bouzom F; Scherrmann JM; Walther B; Declèves X
    Mol Pharm; 2014 Mar; 11(3):836-48. PubMed ID: 24446829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of CSF in translational neuroscience.
    de Lange EC
    J Pharmacokinet Pharmacodyn; 2013 Jun; 40(3):315-26. PubMed ID: 23400635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A translational platform PBPK model for antibody disposition in the brain.
    Chang HY; Wu S; Meno-Tetang G; Shah DK
    J Pharmacokinet Pharmacodyn; 2019 Aug; 46(4):319-338. PubMed ID: 31115858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of triple-probe microdialysis for fast pharmacokinetic/pharmacodynamic evaluation of dopamimetic activity of drug candidates in the rat brain.
    Weikop P; Egestad B; Kehr J
    J Neurosci Methods; 2004 Dec; 140(1-2):59-65. PubMed ID: 15589335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploratory translational modeling approach in drug development to predict human brain pharmacokinetics and pharmacologically relevant clinical doses.
    Kielbasa W; Stratford RE
    Drug Metab Dispos; 2012 May; 40(5):877-83. PubMed ID: 22287668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of human CNS pharmacokinetics using a physiologically-based pharmacokinetic modeling approach.
    Yamamoto Y; Välitalo PA; Wong YC; Huntjens DR; Proost JH; Vermeulen A; Krauwinkel W; Beukers MW; Kokki H; Kokki M; Danhof M; van Hasselt JGC; de Lange ECM
    Eur J Pharm Sci; 2018 Jan; 112():168-179. PubMed ID: 29133240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic evaluation of the use of physiologically based pharmacokinetic modeling for cross-species extrapolation.
    Thiel C; Schneckener S; Krauss M; Ghallab A; Hofmann U; Kanacher T; Zellmer S; Gebhardt R; Hengstler JG; Kuepfer L
    J Pharm Sci; 2015 Jan; 104(1):191-206. PubMed ID: 25393841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active-site concentrations of chemicals - are they a better predictor of effect than plasma/organ/tissue concentrations?
    Hammarlund-Udenaes M
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):215-20. PubMed ID: 20050843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologically Based Modeling Approach to Predict Dopamine D2 Receptor Occupancy of Antipsychotics in Brain: Translation From Rat to Human.
    Wong YC; Centanni M; de Lange ECM
    J Clin Pharmacol; 2019 May; 59(5):731-747. PubMed ID: 30676661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel physiologically based pharmacokinetic modeling of patupilone for human pharmacokinetic predictions.
    Xia B; Heimbach T; Lin TH; He H; Wang Y; Tan E
    Cancer Chemother Pharmacol; 2012 Jun; 69(6):1567-82. PubMed ID: 22526410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic modelling of blood-brain barrier transport of escitalopram in rats.
    Bundgaard C; Jørgensen M; Larsen F
    Biopharm Drug Dispos; 2007 Oct; 28(7):349-60. PubMed ID: 17654695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologically based pharmacokinetic (PBPK) modeling of disposition of epiroprim in humans.
    Luttringer O; Theil FP; Poulin P; Schmitt-Hoffmann AH; Guentert TW; Lavé T
    J Pharm Sci; 2003 Oct; 92(10):1990-2007. PubMed ID: 14502539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition.
    Poulin P; Theil FP
    J Pharm Sci; 2002 May; 91(5):1358-70. PubMed ID: 11977112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a non-human primate model to support CNS translational research: Demonstration with D-amphetamine exposure and dopamine response.
    Folgering JH; Choi M; Schlumbohm C; van Gaalen MM; Stratford RE
    J Neurosci Methods; 2019 Apr; 317():71-81. PubMed ID: 30768951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target-Site Investigation for the Plasma Prolactin Response: Mechanism-Based Pharmacokinetic-Pharmacodynamic Analysis of Risperidone and Paliperidone in the Rat.
    Shimizu S; den Hoedt SM; Mangas-Sanjuan V; Cristea S; Geuer JK; van den Berg DJ; Hartman R; Bellanti F; de Lange EC
    Drug Metab Dispos; 2017 Feb; 45(2):152-159. PubMed ID: 27836941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics meets microdialysis: benefits, pitfalls and necessities of new analysis approaches for human microdialysis data.
    Schaeftlein A; Minichmayr IK; Kloft C
    Eur J Pharm Sci; 2014 Jun; 57():68-73. PubMed ID: 24246313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Insights for Translational Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Studies: Towards Prediction of Nose-to-Brain Transport in Humans.
    Ruigrok MJ; de Lange EC
    AAPS J; 2015 May; 17(3):493-505. PubMed ID: 25693488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous measurement of heroin and its metabolites in brain extracellular fluid by microdialysis and ultra performance liquid chromatography tandem mass spectrometry.
    Gottas A; Oiestad EL; Boix F; Ripel A; Thaulow CH; Pettersen BS; Vindenes V; Morland J
    J Pharmacol Toxicol Methods; 2012 Jul; 66(1):14-21. PubMed ID: 22561414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling.
    de Lange EC; Ravenstijn PG; Groenendaal D; van Steeg TJ
    AAPS J; 2005 Oct; 7(3):E532-43. PubMed ID: 16353931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.